← Leaderboards
Jeffrey L Curtis
University Of Michigan At Ann Arbor
$10,027,931
Attributed
$18,958,461
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2005–24$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$18,958,461 · 5
VA$0 · 1
By mechanism
R01$16,836,296 · 4
U01$2,122,165 · 1
I01$0 · 1
Top collaborators
- Meilan K Han5 shared
- Fernando J Martinez5 shared
- James M Beck3 shared
- Vincent B Young3 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Meilan K Han$16,787,558
- Craig J Galban$12,293,457
- Brian D. Ross$27,286,369
- Laurie K. McCauley$14,844,916
- James J Mule$10,173,865
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungPulmonary EmphysemaResponseImmuneHost DefenseLeadInsightSmokerSmokingPneumoniaChronic Obstructive Airway DiseaseLeukocytesMolecularApoptosisBaseProductionGene ExpressionLinkAlveolar MacrophagesImmune ResponseCytokineGenesCell LineChemokine
Grant awards (30)
Understanding the Origins of Early COPD$2,168,770
R01 · FY2024 · HL
Understanding the Origins of Early COPD$2,101,189
R01 · FY2023 · HL
Understanding the Origins of Early COPD$2,241,348
R01 · FY2022 · HL
Understanding the Origins of Early COPD$2,263,283
R01 · FY2021 · HL
Understanding the Origins of Early COPD$2,499,040
R01 · FY2020 · HL
Modulation of Steroid Suppression by Alveolar Macrophage Efferocytosis$0
I01 · FY2020 · VA · contact PI
Modulation of Steroid Suppression by Alveolar Macrophage Efferocytosis$0
I01 · FY2019 · VA · contact PI
Modulation of Steroid Suppression by Alveolar Macrophage Efferocytosis$0
I01 · FY2018 · VA · contact PI
Modulation of Steroid Suppression by Alveolar Macrophage Efferocytosis$0
I01 · FY2017 · VA · contact PI
Modulation of Steroid Suppression by Alveolar Macrophage Efferocytosis$0
I01 · FY2016 · VA · contact PI
Understanding the Lung Microbiome in HIV-Infected and HIV-uninfected individuals$633,112
U01 · FY2013 · HL · contact PI
Understanding the Lung Microbiome in HIV-Infected and HIV-uninfected individuals$735,944
U01 · FY2012 · HL · contact PI
Understanding the Lung Microbiome in HIV-Infected and HIV-uninfected individuals$753,109
U01 · FY2011 · HL · contact PI
Apoptotic T Cell Clearance From Murine Lungs$283,500
R01 · FY2010 · HL · contact PI
Innate and adaptive immunity in COPD exacerbations$298,628
R01 · FY2009 · HL · contact PI
Apoptotic T Cell Clearance From Murine Lungs$283,500
R01 · FY2009 · HL · contact PI
Innate and adaptive immunity in COPD exacerbations$580,697
R01 · FY2008 · HL · contact PI
Apoptotic T Cell Clearance From Murine Lungs$283,500
R01 · FY2008 · HL · contact PI
Innate and adaptive immunity in COPD exacerbations$592,749
R01 · FY2007 · HL · contact PI
Apoptotic T Cell Clearance From Murine Lungs$283,500
R01 · FY2007 · HL · contact PI
Innate and adaptive immunity in COPD exacerbations$601,914
R01 · FY2006 · HL · contact PI
Innate and adaptive immunity in COPD exacerbations$314,752
R01 · FY2005 · HL
Apoptotic T Cell Clearance From Murine Lungs$283,500
R01 · FY2004 · HL
Apoptotic T Cell Clearance From Murine Lungs$283,500
R01 · FY2003 · HL
Apoptotic T Cell Clearance From Murine Lungs$283,500
R01 · FY2002 · HL
T CELL ADHESION MOLECULES IN MURINE LUPUS PNEUMONITIS$223,030
R01 · FY2002 · HL
Apoptotic T Cell Clearance From Murine Lungs$283,500
R01 · FY2001 · HL
T CELL ADHESION MOLECULES IN MURINE LUPUS PNEUMONITIS$205,396
R01 · FY2001 · HL
PULMONARY LYMPHOCYTE APOPTOSIS AND CELL CYCLE ARREST$276,866
R01 · FY2000 · HL
T CELL ADHESION MOLECULES IN MURINE LUPUS PNEUMONITIS$200,634
R01 · FY2000 · HL